Schering-Plough

  •  15 Apr (PROPUBLICA) –  On the morning of May 3, 2010, three agents of the Food and Drug Administration descended upon the Houston office of Cetero Research, a firm that conducted research for drug companies worldwide.  Lead agent Patrick Stone, now retired from (more…)


  • Nancy Turner Banks MD spent twenty-five years practicing general obstetrics and gynecology during which she was also the director of outpatient gynecology at The North General Hospital in Harlem, New York.  She served as an attending physician at North General, Nyack Hospital in Nyack, New York, Columbia Presbyterian Medical (more…)


  • “At any given moment there is an orthodoxy, a body of ideas which it is assumed that all right-thinking people will accept without question.  It is not exactly forbidden to say this, that or the other, but it is ‘not done’ to say it, just as in mid-Victorian times it was ‘not done’ to mention trousers in the presence of a lady.  Anyone who challenges the prevailing orthodox (more…)


  • Would you buy a home loan from a Countrywide loan rep?  Would you invest your life savings with Bernie Madoff?  Would you ask Casey Anthony to babysit your children?  Probably not. (more…)


  • Since 2004, the pharmaceutical industry has paid $9 billion to settle thousands of criminal and civil complaints related to the illegal marketing of drugs that kill or injure a million Americans EVERY YEAR from adverse drug reactions (ADRs).

    (more…)


  • 24 Dec – Between 1991-2010, there were 165 criminal and/or civil settlements by major pharmaceutical companies comprising of $19.8 billion in penalties.  Before 2000, qui tam lawsuits accounted for only 9% of settlements with the government.  But from 2001-2010, they comprised 67% of the billions in payouts. (more…)


  • 19 Nov – In the pharmaceutical industry’s rush to get drugs to market, safety usually comes last. Long studies to truly assess a drug’s risks just delay profits after all — and if problems do emerge after medication hits the market, settlements are usually less than profits. Remember, Vioxx still made money. (more…)


  • 30 Aug 2010An editorial in The New England Journal of Medicine, by its editor Jeffrey M. Drazen, M.D., and Alastair J.J. Wood, M.D. calls attention to the fact that pharmaceutical companies have tampered with the independent function of the Data Safety Monitoring Board (DSMB) and have planted promotional reports in The NEJM–and other (more…)


  • AGE OF AUTISM – It is self-styled as the largest conversation about science on the web.  Boasting 69 blogs, along with 114,506 posts and 1,742,506 comments that are ever increasing, there is no question “Science”Blogs are highly trafficked and frequently updated. Their slogan brags, “Where the world discusses science,” and crowed a record of 2.2 million unique visitors in the month of May alone. There is now a German “Science”Blogs as well as a “Science”Blogs Brazil written in Portuguese. Their owner, Seed Media Group, likens itself to Rolling Stone during the magazine’s “early years” which according to Seed was “when music was less a subject than a lens for viewing culture.” (more…)


  • By the time Melody Petersen gets around to interviewing Iowa’s state nosologist near the end of “Our Daily Meds,” the facts that she cites don’t even sound that grim. The nosologist’s job is to catalog Iowa’s deceased according to cause of death. He processes about 27,000 death certificates a year. And by his reckoning there were only five deaths caused by adverse reactions to prescription drugs in 2002. That low figure is jarringly out of whack with Ms. Petersen’s investigative reporting (more…)


  • 24 Dec – Between 1991-2010, there were 165 criminal and/or civil settlements by major pharmaceutical companies comprising of $19.8 billion in penalties.  Before 2000, qui tam lawsuits accounted for only 9% of settlements with the government.  But from 2001-2010, they comprised 67% of the billions in payouts. (more…)


  • 19 Nov – In the pharmaceutical industry’s rush to get drugs to market, safety usually comes last. Long studies to truly assess a drug’s risks just delay profits after all — and if problems do emerge after medication hits the market, settlements are usually less than profits. Remember, Vioxx still made money. (more…)


  • 30 Aug 2010An editorial in The New England Journal of Medicine, by its editor Jeffrey M. Drazen, M.D., and Alastair J.J. Wood, M.D. calls attention to the fact that pharmaceutical companies have tampered with the independent function of the Data Safety Monitoring Board (DSMB) and have planted promotional reports in The NEJM–and other (more…)


  • AGE OF AUTISM – It is self-styled as the largest conversation about science on the web.  Boasting 69 blogs, along with 114,506 posts and 1,742,506 comments that are ever increasing, there is no question “Science”Blogs are highly trafficked and frequently updated. Their slogan brags, “Where the world discusses science,” and crowed a record of 2.2 million unique visitors in the month of May alone. There is now a German “Science”Blogs as well as a “Science”Blogs Brazil written in Portuguese. Their owner, Seed Media Group, likens itself to Rolling Stone during the magazine’s “early years” which according to Seed was “when music was less a subject than a lens for viewing culture.” (more…)


  • By the time Melody Petersen gets around to interviewing Iowa’s state nosologist near the end of “Our Daily Meds,” the facts that she cites don’t even sound that grim. The nosologist’s job is to catalog Iowa’s deceased according to cause of death. He processes about 27,000 death certificates a year. And by his reckoning there were only five deaths caused by adverse reactions to prescription drugs in 2002. That low figure is jarringly out of whack with Ms. Petersen’s investigative reporting (more…)


more>>

11 Jun (ALLIANCE FOR NATURAL HEALTH) – Drug companies are deliberately keeping the public—and the medical community—in the dark about “unfavorable” clinical trials. The RECORD trial (see article )  is just one example of how drug study data can be manipulated by pharmaceutical companies and the FDA. But it gets worse— (more…)

AT ISSUE

GM Salmon Rejected by Whole Foods, Trader Joe's, Aldi and Other Retailers

TAKE ACTION

KEY ISSUES

    MORE